类风湿关节炎诊断前自身抗体同型升高的时序模式
基于美国国防部血清库的214例RA病例和210名匹配对照,检测诊断前最多3份和诊断后1份血清中RF及IgA/IgG/IgM型ACPA。结果显示不同自身抗体同型在RA诊断前平均17.9年至5.0年即出现升高,且均呈现早期升高、稳定、诊断前再升高的轨迹,早期升高内型与诊断后生物制剂使用增加及干燥症状和肺病高发相关。
要点
- IgG ACPA在RA诊断前平均17.9年即升高,早于其他同型。
- 所有自身抗体均呈早期升高、稳定、诊断前再升高的三段轨迹。
- 诊断前早期升高内型与诊断后生物制剂使用增加相关。
核心结论
- 不同自身抗体同型在RA诊断前升高的时序模式存在差异,提示RA发病病理生理的阶段性。
- 诊断前早期自身抗体升高内型可能与诊断后表型(生物制剂使用、干燥症状、肺病)相关。
研究设计与样本
- 利用美国国防部血清库识别214例RA病例和210名匹配对照。
- 每例检测最多3份诊断前和1份诊断后血清样本中的RF及IgA、IgG、IgM型ACPA。
主要发现
- 病例组与对照组相比,IgG ACPA平均在RA诊断前17.9年升高,IgA-RF为14.2年,IgM-RF为7.2年,IgA ACPA为6.2年,IgM ACPA和IgG-RF均为5.0年(所有比较P < 0.01)。
- 病例组首次出现IgG ACPA阳性的平均时间为RA诊断前1.9年,IgA-RF为1.7年,其他同型随后出现。
- 仅IgA ACPA阳性在RA诊断后样本中显著增加(诊断前0-2年19% vs 诊断后>2年39%;P = 0.04)。
- 所有自身抗体水平均呈现早期初始升高、一段稳定期、随后在RA诊断前立即升高的模式。
- 诊断前自身抗体早期升高内型与诊断后生物制剂使用增加、干燥症状和肺病患病率更高相关。
临床怎么用
- 对于RA高危人群,可关注IgG ACPA等自身抗体在诊断前多年的动态升高轨迹。
- 识别诊断前早期自身抗体升高内型可能有助于预判诊断后生物制剂需求和关节外表现风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate patterns of elevations of isotypes of rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) pre-rheumatoid arthritis (RA) diagnosis and post-RA diagnosis. METHODS: Using the Department of Defense Serum Repository we identified 214 RA cases and 210 matched controls. Up to 3 pre-RA diagnosis and 1 post-RA diagnosis serum samples per subject were tested for RF and for IgA, IgG, and IgM ACPAs. The timing and trajectories of elevations of autoantibodies were evaluated. RESULTS: Autoantibody levels were elevated in cases versus controls a mean of 17.9 years before RA diagnosis for IgG ACPA, 14.2 years for IgA-RF, 7.2 years for IgM-RF, 6.2 years for IgA ACPA, and 5.0 years for both IgM ACPA and IgG-RF (P < 0.01 for all comparisons). There were similar relationships for positive or negative autoantibody status, with cases first showing positivity for IgG ACPA 1.9 years pre-RA and for IgA-RF 1.7 years pre-RA, followed by the other isotypes. Only IgA ACPA positivity was significantly increased in post-RA diagnosis samples (19% 0-2 years pre-RA versus 39% >2 years post-RA diagnosis; P = 0.04). All autoantibody levels demonstrated an early initial elevation, a period of stability, then an increase immediately before RA diagnosis. A pre-RA endotype of early elevation of autoantibodies was associated with increased use of biologic therapy, and a higher prevalence of sicca symptoms and lung disease post-RA diagnosis. CONCLUSION: Differences in patterns of elevations of autoantibody isotypes have implications for understanding the pathophysiology of RA development. These include understanding what factors drive initial autoantibody elevations compared to what factors (including mucosal) drive later increases in autoantibody levels and a transition to clinically apparent RA, and how pre-RA endotypes may influence post-RA diagnosis phenotypes.
引用
- Kelmenson LB, Wagner BD, McNair BK, et al. Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis. Arthritis Rheumatol. 2019. PMID: 31464042. doi:10.1002/art.41091
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。